Serum levels of Gal-3 are higher in hepatitis, cirrhosis, and hepatocellular carcinoma, though the level of Gal-3 cannot predict HCC development in cirrhotic patients but may be useful for cirrhosis diagnostics [141]. The gene discussed is LGALS3; the disease is hepatocellular carcinoma.